Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 12, 1996, Pages 955-960

  Reeves, Mathew J ^a,b,d   Newcomb, Polly A ^c   Trentham Dietz, Amy ^c   Storer, Barry E ^c   Remington, Patrick L ^a  

^a WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTERVIEWS; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROPIONIC ACIDS; RETROSPECTIVE STUDIES; RISK FACTORS; SIGMOIDOSCOPY; WISCONSIN;

EID: 0029829551     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. American Cancer Society. Cancer Facts and Figures, 1994. Atlanta: American Cancer Society, 1995.
2. Potter, J. D., Slattery, M. L., Bostick, R. M., Gapstur, S. M. Colon cancer: a review of the epidemiology. Epidemiol. Rev., 15: 499-545, 1993.
3. Greenwald, P., and Sondik, E. J., eds., Cancer Control Objectives for the Nation: 1985-2000. National Cancer Institute Monogr., No. 2. Washington DC: United States Government Printing Office, 1986. DHHS Publ. 86-2880.
4. Brownson, R. C., Reif, J. S., Alavanja, M. C. R., and Bal, D. G. Cancer. In: R. C. Brownson, P. L. Remington, and J. R. Davis (eds.), Chronic Disease Epidemiology and Control, 146-149. Washington DC: American Public Health Association, 1993.
5. Greenberg, E. R., and Baron, J. A. Prospects for preventing colorectal cancer death. J. Natl. Cancer Inst., 85: 1182-1184, 1993.
6. Baron, J. A., and Adami, H. O. A broad anticancer effect of aspirin? Epidemiology, 5: 133-134, 1994.
7. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.
8. Kune, G. A., Kune, S., and Watson, L. F. Colorectal cancer risk, chronic illness, operations and medications: case-control results from the Melbourne Colorectal Cancer Study Group. Cancer Res., 48: 4399-4404, 1988.
9. Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., and Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J. Natl. Cancer Inst., 83: 355-358, 1991.
10. Suh, O., Mettlin, C., and Petrelli, N. J. Aspirin use, cancer and polyps of the large bowel. Cancer (Phila.), 72: 1171-1177, 1993.
11. Muscat, J. E., Stellman, S. D., and Wynder, E. L. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer (Phila), 74: 1847-1854, 1994.
12. Peleg, I. I., Maibach, H. T., Brown, S. H., and Wilcox, C. M. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Intern. Med., 154: 394-399, 1994.
13. Thun, M. J., Namboodiri, N. M., and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. New Engl. J. Med., 325: 1593-1596, 1991.
14. Greenberg, E. R., Baron, J. A., Freeman, D. H., Mandel, J. S., and Haile, R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J. Natl. Cancer Inst., 85: 912-916, 1993.
15. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., and Willett, W. C. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121: 241-246, 1994.
16. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E. Aspirin use and the risk of colorectal cancer in women. N. Engl. J. Med., 333: 609-614, 1995.
17. Logan, R. F. A., Little, J., Hawtin, P. G., and Hardcastle, J. D. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br. Med. J., 307: 285-289, 1993.
18. Paganini-Hill, A., Choa, A., Ross, R. K., and Henderson, B. E. Aspirin use and chronic diseases: a cohort study of the elderly. Br. Med. J., 299: 1247-1250, 1989.
19. Gann, P. H., Manson, J. E., Glynn, R. J. Buring, J. E., and Hennekens, C. H. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J. Natl. Cancer Inst., 85: 1220-1224, 1993.
20. Newcomb, P. A., and Storer, B. E. Postmenopausal hormone use and risk of large-bowel cancer. J. Natl. Cancer Inst., 87: 1067-1071, 1995.
21. Newcomb, P. A., Storer, B. E., Longnecker, M. P., Mittendorf, R., Greenberg, E. R., Clapp, R. W., Burke, K. P., Willett, W. C., and MacMahon, B. Lactation and a reduced risk of premenopausal breast cancer. N. Engl. J. Med., 330: 81-87, 1994.
22. Breslow, N. E., and Day, N. E. Statistical methods in cancer research. Vol. 1: the analysis of case-control studies. IARC Scientific Publ. No. 32. Lyon, France: IARC, 1980.
23. Hosmer, D. W., and Lemeshow, S. Applied logistic regression. New York: John Wiley & Sons, 1989.
24. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., and Heath, C. W. Aspirin use and risk of fatal cancer. Cancer Res., 53: 1322-1327, 1993.
25. Sturmer, T., Glynn, R. J., Lee, I. M., Manson, J. E., Hennekens, C. H., and Buring, J. E. Aspirin use and colorectal cancer incidence in the physicians health study (PHS). Am. J. Epidemiol., 143 (Suppl.): S62, 1996.
26. Labayle, D., Fischer, D., Viehl, P., Drouhin, F., Pariente, A., and Borier, C. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101: 635-639, 1991.
27. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., and Celano, P. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
28. Fu, J. Y., Masferrer, J. L., Siebert, K., Raz, A., and Neddleman, P. The induction and suppression of prostaglandin H2 synthetase (cyclooxygenase) in human monocytes. J. Biol. Chem., 265: 16737-16740, 1990.
29. Marcus, A. J. Aspirin as prophylaxis against colorectal cancer. N. Engl. J. Med., 333: 656-657, 1995.
30. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
31. Hixson, L. J., Alberts, D. S., Krutzsch, M., Einsphar, J., Brendel, K., Gross, P. H., Shipp-Paranka, N., Baier, M., Emerson, S., Pamukcu, R., and Burt, R. W. Antiproliferative effects of nonsteroidal anti-inflammatory drugs against human colon cancer cells. Cancer Epidemiol., Biomarkers & Prev, 3: 433-438, 1994.
32. Abramson, S., Korchak, U., Ludewig, R., and Edelson, H. Modes of action of aspirin-like drugs. Proc. Natl. Acad. Sci. USA, 82: 7227-7231, 1985.
33. Abramson, S., Weissman, G. The mechanisms of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum., 32: 1-9, 1989.
34. Baggot, J. E., Morgan, S. L., Ha, T., Vaughn, W. H., and Hine, R. J. Inhibition of folate-dependent enzymes by nonsteroidal anti-inflammatory drugs. Biochem. J., 252: 197-202, 1992.
35. DeMello, D. E., Bayer, B., and Beaven, M. A. Evidence that prostaglandins do not have a role in the cytostatic action of anti-inflammatory drugs. Biochem. Pharmacol., 29: 311-318, 1980.
36. Trujilo, M. A., Harinder, S. G., and Sampliner, R. E. Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. Dig. Dis. & Sci., 59: 2260-2266, 1994.
37. Heath, C. W., Thun, M. J., Greenberg, E. R., Levin, B., Marnett, L. J. Nonsteroidal antiinflammatory drugs and human cancer: Report of an interdisciplinary research workshop. Cancer (Phila.), 74: 2885-2888, 1994.